Stay updated on Troriluzole Long-term Safety in OCD Clinical Trial
Sign up to get notified when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.

Latest updates to the Troriluzole Long-term Safety in OCD Clinical Trial page
- CheckyesterdayChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoChange DetectedThe new version removes the government funding operating-status notice that previously appeared at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe old and new screenshots display the same list of study record versions with no additional status changes or essential data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check51 days agoChange DetectedVersion bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.SummaryDifference11%

- Check58 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

- Check73 days agoChange DetectedThe page revision updated from v3.0.1 to v3.0.2, indicating a new release or patch. The Back to Top navigation element was removed.SummaryDifference0.7%

Stay in the know with updates to Troriluzole Long-term Safety in OCD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole Long-term Safety in OCD Clinical Trial page.